Clinical Trial Update: A Study to Investigate the Efficacy and Safety of Cobimetinib Plus Atezolizumab in Participants With Solid Tumors [Phase 2]

View source ↗

Summary

Phase 2 study evaluating cobimetinib plus atezolizumab in solid tumors has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Atezolizumab (atezolizumab)
• Cobimetinib (cobimetinib)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Solid Tumors | Phase 2 | Status: COMPLETED | Results posted: 2021-03-01